Italia markets open in 3 hours 50 minutes

SWTX Sep 2024 40.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
9,600,00 (0,00%)
In data: 01:21PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente9,60
Aperto9,60
Denaro7,50
Domanda12,10
Prezzo d'esercizio40,00
Scadenza2024-09-20
Min-Max giorno9,60 - 9,60
Contratto - Min-MaxN/D
Volume5
Open Interest3
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (